Drug intelligence / Profile preview

RV001 + lidocaine

Development stage
Unknown
Lead developer
Restore Vision
Modality
Small Molecules
Administration
Topical, Injectable
01

Overview

RV001 + lidocaine is a combination drug product comprised of RV001 and **lidocaine**. Lidocaine is a well-characterized small-molecule amide-type local anesthetic that works by blocking voltage-gated sodium channels in neuronal membranes, thereby inhibiting nerve impulse conduction and resulting in localized numbness. Lidocaine is widely used for local anesthesia during minor surgical or diagnostic procedures, and it is also occasionally combined with investigational drugs for research or specialized clinical purposes. The identity, mechanism, or clinical rationale for the component **RV001** in this combination is not established in current authoritative literature up to September 2025. No definitive information is available as to its pharmacological class, mechanism of action, or disease indication. The inclusion of lidocaine suggests that the product may be used for local anesthesia, potentially for topical or injectable administration.

02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on RV001 + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RV001 + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call